Should prednisone be held in a patient with a urinary tract infection?

No, you do not need to hold prednisone in a patient with a UTI

Prednisone can be safely continued during treatment of a urinary tract infection, but the UTI must be appropriately diagnosed and treated with antimicrobials according to current guidelines. The key is ensuring adequate antibiotic coverage while the patient remains on immunosuppressive therapy.

Understanding the Immunosuppression Risk

The FDA label for prednisone clearly states that corticosteroids "suppress the immune system and increase the risk of infection with any pathogen" and can "reduce resistance to new infections" and "exacerbate existing infections" 1. However, this warning addresses the risk of developing infections while on steroids, not the requirement to discontinue steroids when an infection occurs.

The critical management principle is treating the infection appropriately while continuing necessary corticosteroid therapy, not stopping the steroid.

Clinical Evidence Supporting Continuation

Research specifically examining UTIs in patients on corticosteroids demonstrates that:

• A randomized controlled trial of multiple sclerosis patients receiving methylprednisolone followed by oral prednisone taper showed no significant increase in UTI incidence compared to those receiving methylprednisolone alone 2
• The study concluded that "administering OPT after IVMP did not increase the risk of UTI occurrence" and that routine urinary screening is unnecessary in this population 2

Management Algorithm

1. Diagnose the UTI properly

• Obtain urine culture before starting antibiotics (strong recommendation) 3
• Assess for complicated vs uncomplicated UTI
• Consider that immunosuppression (including corticosteroids) is a complicating factor 3

2. Treat as a complicated UTI

• Patients on immunosuppressive doses of prednisone should be treated as having complicated UTI 3
• Use appropriate empiric antibiotics per EAU guidelines 3:
  • Combination therapy: amoxicillin plus aminoglycoside, OR
  • Second-generation cephalosporin plus aminoglycoside, OR
  • IV third-generation cephalosporin
• Fluoroquinolones only if local resistance <10% and specific criteria met 3
• Treatment duration: 7-14 days (14 days for men when prostatitis cannot be excluded) 3

3. Continue prednisone with specific precautions

• Do not abruptly discontinue prednisone - the FDA label explicitly warns against abrupt withdrawal 1
• If the patient is on chronic prednisone and experiencing infection stress, dosage may need to be increased, not decreased 1
• The FDA states: "in any situation of stress occurring during that period, hormone therapy should be reinstituted. If the patient is receiving steroids already, dosage may have to be increased" 1

4. Monitor closely

• Watch for signs of worsening infection or progression to urosepsis
• Assess for systemic symptoms using qSOFA criteria if concerned about sepsis 3
• Tailor antibiotics based on culture results 3

Important Caveats

Abrupt prednisone withdrawal is dangerous: The FDA label warns that "adrenocortical insufficiency may result from too rapid withdrawal of corticosteroids" and this "type of relative insufficiency may persist for up to 12 months after discontinuation of therapy" 1. During the stress of an acute infection, stopping prednisone could precipitate adrenal crisis.

Consider the underlying indication: If prednisone is being used for a life-threatening condition (e.g., severe autoimmune disease, organ transplant rejection prevention), the risk of stopping it far outweighs the theoretical benefit of reducing immunosuppression during a treatable UTI.

Recognize drug-related UTI risk: While corticosteroids are associated with increased UTI risk 4, 5, this is a reason for heightened surveillance and prompt treatment, not discontinuation of necessary therapy.

Special Populations

In elderly or frail patients on prednisone, UTI diagnosis may be complicated by atypical presentations including confusion or functional decline 6. Maintain a high index of suspicion and use a holistic diagnostic approach in these patients while continuing necessary corticosteroid therapy.